Interaction of Heparin with Lipoproteins – Role of the Complex in the Inactivation of Thrombin and Plasmin

Summary

Heparin forms a complex with human low density lipoprotein (LDL) in the presence of Ca²⁺. The complex is dissociable by 0.5 M NaCI. Thrombin and plasmin causes the dissociation of the LDL-heparin complex, whereas factor Xa does not. Heparin, complexed with LDL, retains its enhancing effect on the rate of thrombin and plasmin inactivation by antithrombin III. LDL isolated from the plasma of persons with different pathological conditions did not alter the rate of thrombin inactivation by antithrombin III either in the absence or in the presence of heparin. Heparin seems to maintain its biological functions when it is in a complex with LDL.

Keywords

Heparin - High density lipoproteins - Low density lipoproteins - Thrombin - Plasmin - Factor Xa - Antithrombin III

• References

• 1 Estes JW. Clinical pharmacokinetics of heparin. Clin Pharmacokinet 1980; 5: 204-220
• 2 Marciniak E. Binding of heparin in vitro and in vivo to plasma proteins. J Lab Clin Med 1974; 84: 344-356
• 3 Srinivasan SR, Randhnakrishnamurity B, Berenson G. Studies on the interaction of heparin with serum lipoproteins in the presence of Ca²⁺, Mg²⁺ and Mn²⁺ . Arch Biochem Biophys 1975; 170: 334-340
• 4 Shelburne FA, Quartfordt SH. The interaction of heparin with an apoprotein of human very low density lipoprotein. J Clin Invest 1977; 60: 944-950
• 5 Mookerjea S. Mechanism of heparin and serum lipoprotein interaction: Effect of calcium, phosphorylcholine and a serum fraction. Can J Biochem 1978; 56: 746-752
• 6 Skinner ER, Rooke JA. Fractionation of rat plasma lipoproteins by affinity chromatography on heparin-Sepharose. Comp Biochem Physiol 1980; 65 B: 645-650
• 7 MacGregor JR, Lane DA, Kakkar VV. The anti-heparin properties of human low-density lipoprotein. Biochim Biophys Acta 1980; 617: 472-479
• 8 Lane DA, MacGregor JR. Low-density lipoprotein: a selective inhibitor of the heparin-accelerated neutralisation of factor Xa by antithrombin III. In: Chemistry and Biology of Heparin. Lundblad RL, Brown WV, Mann KG, Roberts HR. (Eds), pp. 301-307 Elsevier – North Holland: 1981
• 9 Rosenberg R, Oosta GM, Jordan RE, Gardner WT. Mechanism of antithrombin action and the structural basis of heparin's anticoagulant function. In: Chemistry and Biology of Heparin. Lundblad RL, Brown WV, Mann KG, Roberts HR. (Eds), pp. 249-269 Elsevier – North Holland:
• 10 Machovich R, ArSnyi P. Effect of heparin on thrombin inactivation by antithrombin HI. Biochem J 1978; 173: 869-875
• 11 Jaques LB, Kavanagh LW, Kuo SH. Variations in chemical parameters and anticoagulant potencies of commercial heparin and its relation to the problem of heparin standardized for clinical use. Thromb Res 1973; 3: 295-306
• 12 Fenton II JW, Fasco MJ, Stackrow AB. Human thrombins. J Biol Chem 1977; 252: 3587-3598
• 13 Lundblad RL, Uhteg LC, Vogel NC, Kingdon HS, Mann KG. Preparation and partial characterization of two forms of bovine thrombin. Biochem Biophys Res Commun 1975; 66: 428-489
• 14 Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 15 Machovich R, Bauer PI, Arányi P, Kecskés É, Büki KG, Horváth I. Kinetic analysis of the heparin enhanced plasmin-antithrombin III reaction. Apparent catalytic role of heparin. Biochem J 1981; 199: 521-526
• 16 Blaskd G, Machovich R. Decreased heparin sensitivity of cyclo-hexanedione-modified factor Xa. Thromb Haemostas 1979; 42: 556-563
• 17 Wickerhauser M, Williams C, Mercier J. Development of large scale fractionation methods. VII. Preparation of anti thrombin III concentrate. Vox Sang 1979; 36: 281-293
• 18 Orakzai AS, Machovich R. Inactivation of α- and β-thrombin by heat-defibrinated human plasma. Effect of heparin. Thromb Res 1977; 10: 813-822
• 19 Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1353
• 20 Hatton MWC, Berryl RL, Machovich R, Regoeczi E. Tritiation of commercial heparin by reaction with NaB³H₄: Chemical analysis and biological properties of the product. Anal Biochem 1980; 106: 417-427
• 21 Jaques LB, Bell HS. The determination of heparin. Methods Biochem Anal 1959; 7: 253-309
• 22 Lowry OH, Rosebrough HJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 23 Summaria L, Hsieh B, Grosskopf NR, Robbins KC, Barlow GH. The isolation and characterization of the S-carboxymethyl (light) chain derivative of human plasmin. J Biol Chem 1967; 242: 5046-5052
• 24 Miller-Andersson M, Borg H, Andersson LO. Purification of antithrombin III by affinity chromatography. Thromb Res 1974; 5: 439-452
• 25 Hilbom JC, Anastassiadis PA. Estimation of the molecular weights of acidic mucopolysaccharides by polyacrylamide gel electrophoresis. Anal Biochem 1971; 31: 51-59
• 26 Machovich R, Regoeczi E, Hatton C. The influence of heparin, NaCI and CaCl₂ on the rate of the thrombin-antithrombin III reaction. Thromb Res 1979; 15: 821-834
• 27 Gitel SN. Evidence of catalytic role of heparin in anticoagulation reactions. Adv Exp Med Biol 1975; 52: 243-247
• 28 Stürzebecher J, Markwardt F. Role of heparin in the inhibition of thrombin, Factor Xa and plasmin by antithrombin III. Thromb Res 1977; 11: 835-846
• 29 Griffith MJ, Kingdon HS, Lundblad RJ. Inhibition of the heparin- antithrombin III/thrombin reaction by active site blocked-thrombin. Biochem Biophys Res Commun 1979; 87: 686-692
• 30 Machovich R. Mechanism of action of heparin through thrombin on blood coagulation. Biochim Biophys Acta 1975; 412: 13-17
• 31 Hatton MWC, Regoeczi E. The inactivation of thrombin and plasmin by antithrombin in in the presence of Sepharose-heparin. Thromb Res 1977; 10: 645-660
• 32 Machovich R, Staub M, Patthy L. Decreased heparin sensitivity of cyclohexanedione-modified thrombin. Eur J Biochem 1978; 83: 473-477
• 33 Griffith MJ. Kinetic analysis of the heparin enhanced antithrombin III/thrombin reaction. J Biol Chem 1979; 254: 12044-12049
• 34 Smith GF, Sundboom JL. Heparin-plasmin and heparin-trypsin complexes in solution. Relevance to α-antithrombin function and heparin pharmacology. In: Chemistry and Biology of Heparin. Lundblad RL, Brown WV, Mann KG, Roberts HR. (Eds), pp. 317-323 Elsevier – North Holland: 1981
• 35 Pan YT, Kruski AW, Elbein AD. Binding of [³H]-heparin to human plasma low density lipoprotein. Arch Biochem Biophys 1978; 189: 231-240
• 36 Smith GF, Sundboom JL. Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin and trypsin. Thromb Res 1981; 22: 103-114